EdgarLookup
8-K

FORM 8-K

Company
BRAINSTORM CELL THERAPEUTICS INC.
Filed
March 2, 2017
Period of Report
February 26, 2017
Accession Number
0001144204-17-012335

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →